AccuSift provides high‑performance furosemide competitive assay pairings, characterized by exceptional batch‑to‑batch consistency and optimized for IVD kit development (Lateral Flow, Chemiluminescence, ELISA, POCT). These pairings offer high affinity and specificity, facilitating rapid detection.Furosemide is a potent diuretic, mainly used to treat edema caused by heart, liver, kidney, and other diseases.On October 27, 2017, the World Health Organization’s International Agency for Research on Cancer (IARC) listed furosemide in its preliminary compilation of Group 3 carcinogens.Performance Characteristics:
•Sensitivity: ELISA IC50: 0.5 ppb
•Source: Mouse Monoclonal Antibody
•Purity: ≥ 90%
•Recommended Pairing: (Coating) / (Labeling)
•Storage: Long‑term storage at ≤ –20°C; short‑term storage at 2–8°C. Shipped on ice packs.